Understand the how the therapy of hypothyroidism has evolved since the first use of thyroid gland preparations |
|
|
Describe how TSH references intervals may vary for different populations and understand the impact of TSH values on outcomes, morbidity, and mortality |
|
|
List the factors other than serum TSH values, such as T3 levels and polymorphisms in TH transporters and deiodinases, that may potentially provide information about the thyroid status of patients |
|
|
Describe the potential benefits and risks of combination therapy, and weigh these factors in order to determine whether combination therapy should be offered to patients with hypothyroidism |
|
|
Review areas with significant knowledge gaps, such as whether measuring additional thyroid analytes beyond TSH and FT4 is helpful, and whether diet/dietary supplements impact thyroid function |
|
|
Describe how patient-centered outcomes might be incorporated into the management of patients with hypothyroidism |
|
|
Appreciate the patient perspective during the treatment of hypothyroidism |
|
|